Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients.

By D. Blockmans, L. de Ceuninck, S. Vanderschueren, D. Knockaert, L. Mortelmans, H. Bobbaers. Arthritis & Rheumatism, 2006

622 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/d0956dd0286a0d2b9090d07a95c9eb78d8b82ed6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. B. Hellmich
2. R. Watts
3. M. Cid
4. C. Mukhtyar
5. T. Hauser
6. C. Salvarani
7. R. Luqmani
8. L. Guillevin

Citations in the corpus

• EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice (2018, background): “41 While PET scores significantly dropped from baseline to 3 months, there was no further reduction at 6 months.”
• EULAR recommendations for the management of large vessel vasculitis (2008, background): “Aortic imaging should be considered in giant cell arteritis, especially in patients with an aortic insufficiency murmur,(73) because subclinical involvement is common and may progress to form aneurysm or dissection in 9%–18% of patients.(14) 73–76 In symptomatic patients, the presence of normal infl”